Catalyst Pharmaceuticals (CPRX) Free Cash Flow (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Free Cash Flow of $59.6 million for Q1 2026, up 32.77% on a QoQ basis from $44.9 million in Q4 2025, and down 0.8% year-over-year from $60.0 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Free Cash Flow (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Free Cash Flow history runs 17 years deep, the most recent figure standing at $59.6 million for Q1 2026.
- Quarterly Free Cash Flow fell 0.8% year-over-year to $59.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $208.1 million (down 22.21% YoY) and the FY2025 annual result came in at $208.6 million, down 12.81% from the prior year.
- Free Cash Flow was $59.6 million for Q1 2026 at Catalyst Pharmaceuticals, up from $44.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $72.6 million in Q3 2024 and bottomed at $8.5 million in Q1 2022.
- A 5-year average of $45.1 million and a median of $44.9 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow jumped 192.04% — and 2025, when it sank 55.33%.
- Catalyst Pharmaceuticals' Free Cash Flow stood at $40.1 million in 2022, then soared by 38.62% to $55.6 million in 2023, then climbed by 27.42% to $70.8 million in 2024, then tumbled by 36.63% to $44.9 million in 2025, then jumped by 32.77% to $59.6 million in 2026.
- Business Quant data shows CPRX's Free Cash Flow at $59.6 million in Q1 2026, $44.9 million in Q4 2025, and $32.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 59.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.56 Mn |
| Mar 31, 2026 | 59.56 Mn |
| Dec 31, 2025 | 44.86 Mn |
| Dec 31, 2025 | 44.86 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Jun 30, 2025 | 71.27 Mn |
| Jun 30, 2025 | 71.27 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Dec 31, 2024 | 70.79 Mn |
| Dec 31, 2024 | 70.79 Mn |
| Sep 30, 2024 | 72.61 Mn |
| Sep 30, 2024 | 72.61 Mn |
| Jun 30, 2024 | 64.13 Mn |
| Jun 30, 2024 | 64.13 Mn |
| Mar 31, 2024 | 31.73 Mn |
| Mar 31, 2024 | 31.73 Mn |
| Dec 31, 2023 | 55.56 Mn |
| Dec 31, 2023 | 55.56 Mn |